Max G. Ostermeier (MBA), is a medical device serial entrepreneur and founder and CEO of Implandata Ophthalmic Products. Prior to that Max was CEO and founder of Cranium Telemetrics, a start-up which has developed the first implantable intracranial pressure sensor for better management of hydrocephalus patients. He also founded and managed Odicrain, a medical device company with a portable device for early detection of critical brain injuries. For both companies, a successful exit was accomplished with large medical device companies. Previous to starting his own companies, Max was responsible to establish Proligo LLC in Boulder Colorado, which became a leader in DNA/RNA synthesis reagents for the biopharma, pharma and diagnostic industry. The company was acquired by Sigma Aldrich in 2004.
Max G. Ostermeier (MBA), is a medical device serial entrepreneur and founder and CEO of Implandata Ophthalmic Products. Prior to that Max was CEO and founder of Cranium Telemetrics, a start-up which has developed the first implantable intracranial pressure sensor for better management of hydrocephalus patients. He also founded and managed Odicrain, a medical device company with a portable device for early detection of critical brain injuries. For both companies, a successful exit was accomplished with large medical device companies. Previous to starting his own companies, Max was responsible to establish Proligo LLC in Boulder Colorado, which became a leader in DNA/RNA synthesis reagents for the biopharma, pharma and diagnostic industry. The company was acquired by Sigma Aldrich in 2004.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy